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WE investigated the participation of lipid media-
tors in an experimental immune complex (IC)
arthritis model in rats. The animals were sub-
jected to intraarticular injection of anti-bovine
sertLm albumin (BSA) IgG antibodies followed by
i.v. injection of BS/L Histopathological analysis of
the synovial membranes disclosed infiltration of
polymorphonuclear (PMN) cells and vascular
congestion. Slight increase in vascular permeabil-
ity, measured by Evans blue dye extravasation
into the joints, was detected after 3h of arthritis.
Cellular influx into the articular cavities was
most evident at the sixth hour of arthritis with
predominance of PMN. Pretreatment with either
indomethacin, a cyclooxygenase inhibitor, or L-
660,711, a peptido-leukotriene antagonist, did not
inhibit cell infiltration, whereas pretreatment
with either L-663,536, a 5-lipoxygenase inhibitor,
or L-655,240, a thromboxane antagonist, signifi-
cantly inhibited the phenomenon. Pretreatment
with WEB 2170, a platelet activating factor (PAF)
antagonist, also significantly inhibited cell influx.
These results suggest that thromboxane, LTB4
and PAF mediate cell infiltration in this IC arthri-
tis model.
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Introduction
Immune complex (IC) deposition is an impor-
tant event in the pathogenesis of rheumatoid
arthritis (RA). This assumption is supported by
the detection of IC deposits in the synovium and
articular cartilage, as well as by the possibility of
rheumatoid factor self-aggregation in large insolu-
ble immune complexes and the association of
circulating immune complexes with disease
severity in some RA patients. The most com-
monly used experimental models of RA, the
antigen-induced arthritis and the adjuvant-
induced arthritis, exhibit close resemblance to
the pathophysiology of RA. However, they do not
allow a precise investigation of the isolated con-
tribution of IC to the development of arthritis.
Induction of a reverse passive Arthus reaction
in rabbit knee joints promotes a modest increase
in vascular permeability, pronounced cellular
infiltration, mostly polymorphonuclear (PMN)
neutrophils, and cartilage destruction, being con-
sidered as a suitable experimental model to
study the mechanisms involved in articular
lesions dependent on IC formation.
2 Although
the recruitment and activation of these cells in
IC-induced lesions is considered essential to the
full-blown development of the reaction, the
factors governing these phenomena are still
obscure.
Previous data have shown that eicosanoids
and platelet activating factor (PAF) are involved
in IC disease models. These lipid mediators
can alter vascular permeability and microcircula-
tory blood flow. In addition, they promote cell
migration and activation, causing release of
other inflammatory mediators as well as reac-
tive oxygen intermediates and lysosomal
enzymes, which are effectors of local tissue
damage. Detection of prostaglandin E2, leuko-
triene B4 and thromboxane B2 in the broncho-
alveolar lavage fluid
4 and peritoneal exudate5 in
Arthus reactions in rats argues for the partici-
pation of these substances in IC-induced
lesions. Moreover, lung haemorrhagic lesions
induced by IC were shown to be mediated by
PAF and LTB4.6 However, the role of these
mediators in IC-induced arthritis has not been
established yet.
The aim of the present study was to character-
ize the early events of an arthritis caused exclu-
sively by immune complexes. To this purpose, a
reverse passive Arthus reaction was induced in
the knee joint of rats. Synovial histopathological
alterations, vascular permeability, and cell influx
into the joints were evaluated. The contribution
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of PAF and eicosanoids to cell infiltration into were determined using a Neubauer chamber. Dif-
the joints was also investigated, ferential counts were performed on fixed and
stained cell suspensions (0.05% ceystal violet dis-
Materials and Methods solved in 30% acetic acid).
Animals.. Male Wistar rats (250-350 g) from our Drug treatments: Groups of animals were treated
own animal facilities were used throughout the with the following drugs 30min prior to arthritis
experiments, induction: indomethacin (4mg/kg, i.v.); WEB
2170 (5 mg/kg, i.v.); L-660,711 (10mg/kg, i.v.); L-
Induction ofpassive reverse arthus reaction in 655,240 (5 mg/kg, i.v.). The compound L-663,536
the knee joints.. Rats were anaesthetized by i.p. (10mg/kg, per os), was injected 20h prior to
injection of chloral hydrate (400mg/kg). Rabbit arthritis.
IgG antibodies to BSA (2001.tg in 0.1 ml saline)
were injected into the knee joints, followed by Drugs and reagents.. The compounds L-663,536,
i.v. injection of I mg BSA in 0.2 ml saline. Control L-660,711, and L-655,240 were kindly supplied by
animals received the same amount of the anti- Merck Frosst Lab., Canada, and WEB 2170 by
body intraarticularly followed by saline injection Boehringer-Ingelheim, Germany. Indomethacin,
i.v. BSA, rabbit IgG anti-BSA antibodies, and FITC-
labelled goat anti-rabbit IgG were purchased
Collection ofsynovial exudate: The animals were from Sigma Chem Co., USA, and FITC-labelled
anaesthetized and killed by ceeeical dislocation goat anti-human IgG from Hemagen, USA.
and exsanguinated. The synovial cavity of the
knee joints was then washed with 0.4ml saline Statistical analysis.. ANOVA or Student’s t-test
containing 5 U/ml heparin. The exudates were were used to compare means, p < 0.05 was con-
collected by aspiration, centrifuged (500 x g for sidered significant.
10 min) and the cell-free supernatant stored at
-20C for further analysis. Results
Evaluation of increase in vascular permeability: An Arthus reaction was induced by injection of
Groups of animals received i.v. injection of Evans rabbit anti-BSA IgG antibodies into the articular
blue dye (20mg/kg), dissolved in saline, 15 min cavity of rats, followed by i.v. injection of the
prior to arthritis induction. The animals were antigen (IC group). The control group received
sacrificed at different times and the synovial an injection of the antibody into the articular
exudate collected for determination of the cavity and saline i.v.
amount of extravasated dye. The concentration
of the dye was determined colorimetrically at Histopathological analysis.. Figure I(A) illustrates
630nm and compared to a standard curve, a synovium specimen obtained 6h after arthritis
Results were expressed as l.tg of Evans blue per induction, showing interstitial haemorrhage and
ml of exudate, infiltration of PMN cells. The control groups
exhibited none of these alterations (not
Histopathological analysis and immunofluores- shown). The direct immunofluorescence, using
cence technique: Synovial tissue sections were FITC anti-rabbit IgG, aspect of a synovium spe-
processed for routine haematoxylin-eosin stain- cimen from a rat subjected to the Arthus reac-
ing and also for direct immunofluorescence, tion is depicted in Fig. I(B), showing granular
Briefly, 3 l.tm thick cryosections of synovial IC deposits which were not seen in the control
tissues were mounted on glass slides, fixed in group (not shown). A direct immunofluores-
acetone at 20C for 8min, and air-dried. Tissue cence using anti-human IgG conjugate did not
sections were incubated with FITC-labelled goat show fluorescence staining, thus ensuring the
anti-rabbit IgG or FITC-labelled goat anti-human specificity of the anti-rabbit IgG conjugate used
IgG diluted to 1:100 in PBS (0.1 M NaCl, pH7.2) (data not shown).
for 30 min at 37C in wet chamber. After washing
twice in PBS for 10 min, slides were mounted in Increase in vascular permeability: The alteration
glycerine at pH 9.0 and observed by using fluor- in vascular permeability, measured as the concen-
escence microscopy, tration of Evans blue dye extravasated into the
joint cavity was evaluated 10 min, 30 min, I h, and
Cell counting: The synovial exudates were centri- 3 h after arthritis induction. A significant (p <
fuged (500 x g for 10min) and the cell pellet 0.05) increase in extravasation of the dye was
resuspended in 0.1ml saline. Total cell counts observed only in the 3h exudates, being 0.59tg/
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FIG. 2. Polymorphonuclear and mononuclear cell counts in the
synovial cavity of rats 6h (A) or 24h (B) after induction of IC
arthritis (IC). Control groups (C) received the antibodies intraarti-
cularly and saline i.v. Data represent the mean ___
S.E.M. (n
6-8 animals). *p < 0.05 as compared to the control group
using Student’s t-test.
Role of lipid mediators on the cellular influx.. In
order to investigate the role of eicosanoids and
PAF in the cell influx into the knee joints, we
studied the effect of treating the animals with
indomethacin (a cyclooxygenase inhibitor), L-
663,536 (a lipoxygenase inhibitor), L-655,240 (a
thromboxane antagonist), L-660,711 (a peptido-
leukotrienes antagonist) or WEB 2170 (a PAF
antagonist) prior to arthritis induction. Figure 3
shows that pretreatment with either indometha-
cin or L-660,711 did not alter the number of cells
present in the exudate collected 6 h after induc-
FIG. 1. (A) Synovial section from rats 6h after induction of tion of the reaction. Pretreatment with either L-
immune complex arthritis, showing interstitial haemorrhage and
polymorphonuclear cell inflammatory infiltrate. (Haematoxylin- 655,240, WEB 2170 or L-663,536 caused a
eosin; original magnification x 400.)(B) Direct immunofluores- decrease of 77%, 69%, and 54.7% in cell counts,
cence of synovial section of rats 6h after induction of IC arthri- respectively. The efficacy of the inhJbitors indo-
tis, showing granular IC deposits, which were not seen in the
control group (original magnification x 400). methacin and L-663,536 was confirmed by using
ELISA to evaluate their effect on POE2 and LTB4
release into the synovial exudates. Indomethacin
ml (n 8), compared with 0.21 I.tg/ml (n 5) completely blocked PGE2 release whereas L-
in the control group. 663,536 caused an 80% reduction of LTB4 release
(data not shown). These results suggest that
Cellular influx into the knee joints: Figure 2 thromboxane, PAF and leukotriene B4 are
shows the cell counts in the synovial exudates Of involved in cell migration in this IC arthritis
the IC and control groups after 6 h (A) and 24 h model.
(B) of arthritis induction. After 6 h of arthritis,
the total number of leukocytes was about nine Discussion times greater in the IC group (1924 _
264.66 x
10 cells/ml) compared with the control group In this IC arthritis model, the groups subjected
(213.32 ___
37.56 x 10 cells/ml), with a pre- to the reverse passive Arthus reaction were
dominance of PMN cells. After 24h of arthritis, always compared to the group that received the
there was still a statistically significant difference antibody intraarticularly, but not the antigen.
between the two groups although, at this time, Since the mere administration of antibody into
the difference was due to a five times greater the joints may result in a mild synovitis, the com-
number of mononuclear cells in the IC group, parison of both groups was essential to allow
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FIG. 3. Effect of treatment on the cellular influx into the synovial
cavity of rats, 6 h after induction of IC arthritis. The first group
received no treatment and the subsequent ones were pretreated
with indomethacin (4mg/kg i.v., n 5), WEB 2170 (5mg/kg
i.v., n 9), L-660,711 (lOmg/kg i.v., n 4), L-655,240 (5mg/
kg i.v., n 6), L-663,536 (10 mg/kg per os, n 7). Data repre-
sent the mean ___
S.E.M. *p < 0.05 as compared to the control
group, using one-way ANOVA.
the study of the inflammatory process induced
solely by the deposition of immune complexes.
The histopathological analysis revealed vascular
congestion and cellular infiltrate, composed
mainly of neutrophils at 6 h and mononuclear
cells at 24h. Similar findings were reported in
rabbits subjected to IC arthritis.
2 The demonstra-
tion of granular immunofluorescent deposits in
the synovia of the rats subjected to the Arthus
reaction, but not in the control group, provides a
strong indication that the inflammatory changes
were mostly caused by IC deposition in the syno-
vial tissue.
The increase in vascular permeability as meas-
ured by the analysis of the concentration of
Evans blue dye extravasated to the synovial cavity
was significant only when measured over a
period of 3 h following induction of the reaction.
These results differ from those obtained in a
model of active Arthus reaction in rabbits, where
a significant increase in vascular permeability was
observed] Since active immunization induces
production of precipitating antibodies as well as
antibodies cytophylic for mast cells, the latter
would promote release of mast cell derived med-
iators which would account for the increased
vasopermeability. In the present study, we used
rabbit IgG antibodies which are not cytophylic
for rat mast cells, in order to ensure a reaction
mediated predominantly by immune complexes.
In this case, increase in vascular permeability is
not a prominent event, as we have previously
reported in IC-induced alveolitis. One possible
speculation is that, in this type of reaction, there
is a release of vasoconstricting substances which
may limit plasma extravasation. In support of this
assumption, it was shown that release of slow
reacting substance of anaphylaxis (SRS-A) in
passive Arthus reaction markedly inhibited carra-
geenin oedema,s
The infiltration of inflammatory cells into the
synovial cavity peaked 6 h after arthritis induction,
with a predominance of PMN cells, and declined
after 24 h, when mononuclear cells became pre-
dominant. These results are in accordance with
previous data showing leukocyte infiltration in
the reverse passive Arthus reaction in rabbit
joints
2 as well as in the antigen-induced arthritis
model.7,9
Pretreatment with specific inhibitors or an-
tagonists of eicosanoids and PAF showed that
inhibition of leukotriene synthesis by compound
L-663,536,1 as well as antagonism of thrombox-
ane by L-655,24011 or of PAF by WEB 217012
inhibited cellular influx into the synovial cavities.
Inhibition of cyclooxygenase by indomethacin or
antagonism of peptido-leukotrienes by com-
pound L-660,711 did not affect cell influx.
That the concentrations of the inhibitors used
in this study were adequate was confirmed by
the reduction of LTB4 and PGE2 levels in the
synovial exudates by L-663,536 and indometha-
cin, respectively. The concentration of the PAF
antagonist, WEB 2170, was assayed against PAF-
induced vasopermeability in rats, being 5mg/
kg--the dose that provoked the best inhibition.
A recent publication from our group demon-
strates the efficacy of this dose on PAF-induced
vascular permeability in rat lungs.
14 The concen-
tration of L-655,240 was taken from a relevant
published report where this compound selec-
tively antagonized the effects of a thromboxane
analogue both in vivo and in vitro.
1 The
peptido-leukotriene antagonist L-660,711 was
used at doses ten times higher than those
reported to inhibit antigen-induced bronchocon-
striction in sensitized rats.13
The fact that an inhibitor of 5-1ipoxygenase
inhibited cell influx whereas an antagonist of
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peptido-leukotrienes had no effect suggests that illustrated by its detection in the synovial fluid of
leukotriene B4 is responsible for this phenom- experimental models of arthritis.25 Furthermore,
enon. Taken together, these results suggest that it was reported that PAF contributes to cell
LTB4, thromboxane, and PAF contribute to cell migration in the antigen-induced arthritis model
infiltration in IC arthritis, in rabbits, an effect that could result from either
The presence of LTB4 in the synovial fluid of a direct action of PAF or an indirect one via the
arthritis patients has already been demon- release of other inflammatory mediator(s).2 We
strated.15 Moreover, neutrophils and macro- have recently observed that the PAF antagonist
phages from RA patients stimulated with calcium WEB 2170, but not indomethacin, L-663,536 or L-
ionophore A23187 release more LTB4 than do 655,240 inhibited TNF release in this IC arthritis
those of healthy volunteers.16 Besides promoting model (Rocha et al., submitted). These results
PMN adhesion to vascular endothelial cells,
1 suggest that the effect of PAF on cell migration
LTB4 is also a potent chemoattractant to both might be through TNF release. It also points to
neutrophils and macrophages.
18 However, few interesting interactions between lipid mediators
studies have focused on the importance of leuko- and cytokines. Another mechanism that might
trienes in arthritis. To our knowledge, this is the contribute to cell migration is related to comple-
first demonstration that LTB4 contributes to leu- ment activation. However, we believe that C5
kocyte infiltration in arthritis, fragments are not essential for cell migration in
Non-steroidal anti-inflammatory drugs IC reactions, based on previous observations that
(NSAIDs) are the most commonly prescribed the temporal profile of neutrophil accumulation
substances to treat RA patients. It is well known in response to IC deposition is similar in coiso-
that these drugs provide only symptomatic relief genic strains of mice, where one of them is
to RA patients, without altering the disease genetically deficient in the C5 component.
2
outcome. This could be due to the cessation of The exact role of neutrophils in the pathogen-
an inhibitory effect of the cyclooxygenase prod- esis of arthritis is a subject of debate. Although it
ucts on leukotrienes synthesis19 or by a preferen- seems indisputable that these cells are responsi-
tial shift of the substrate pool into the lipoxygen- ble for the release of inflammatory mediators,
ase pathway, thus enhancing leukotriene lysosomal enzymes and reactive oxygen species,
20 production. This putative increase in leuko- a direct role for them in mediating cartilage
triene release could partially explain the lack of breakdown is not clearly established. In an IC
efficacy of NSAIDs in modifying the natural arthritis model in mice it was suggested that
course of RA. these cells are involved in cartilage destruction.
2s
Previous data have shown that thromboxane However, in the antigen-induced arthritis model
A2 is chemotactic to mouse neutrophils in in rabbits, it was suggested that neutrophils
vitro.
21 Additionally, econazole, an imidazole might not be essential for cartilage degradation,
compound which inhibits thromboxane synth- since the animals still presented cartilage break-
esis, inhibited cell infiltration in carrageenin down after being rendered neutropenic by pre-
pleurisy.
22 This effect of thromboxane could be treatment with nitrogen mustard.9 More recently,
explained by its ability to enhance neutrophil in an in vitro study, it was demonstrated that
adhesion to endothelial cells, via activation of the neutrophils were able to degrade both proteogly-
CD18 receptor on neutrophils.
23 In our experi- cans and collagen in human cartilage, an effect
ments, the thromboxane antagonist significantly that was facilitated by previous stimulation of the
inhibited cell influx, suggesting that thrombox- neutrophils with immunoglobulins.
29 Such data
ane is involved in cell migration in arthritis. We are corroborated by previous studies suggesting
have previously demonstrated that thromboxane that immunuglobulins might facilitate neutrophil
is involved in PAF-induced vasoconstriction in adhesion to cartilage surface, where these cells
the synovial microcirculation of normal rabbit could then be activated. Another explanation
joints.
24 Our present data indicating the participa- could be that activation of the Fc receptor of
tion of LTB4 and TXB2 in the cell infiltration in previously primed neutrophils might potentiate
this IC arthritis model suggest that these lipid the release of inflammatory mediators, as well as
mediators may have a more important regulatory release of reactive oxygen species and lysosomal
role on inflammatory arthropathies than has pre- enzymes by these cells, thus resulting in
viously been ascribed to them. increased tissue damage.
Our results also showed that pretreatment of Since IC deposition is involved in some rheu-
the animals with WEB 2170, a specific PAF matic conditions, including rheumatoid arthritis,
antagonist, significantly reduced cell infiltration, systemic lupus e/thematosus and vasculitis, the
thus implicating PAF in this phenomenon. The possibility of studying the mechanisms governing
potential importance of PAF in arthritis can be IC-induced lesions in joints makes this model
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relevant to the understanding of the pathophy-
siology of synovitis.
The IC arthritis model described here proved
to be a suitable and reproducible model of
experimental arthritis. The participation of eico-
sanoids, mainly leukotrienes and thromboxane,
as well as PAF in the regulation of cell migration
described here suggests that inhibitors or antago-
nists of these substances might be valuable alter-
natives to the therapy for inflammatory
arthropathies.
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